Nicotine therapeutic benefits: Difference between revisions

Jump to navigation Jump to search
Moving suggestions to their categories
(Adding infection, etc category)
(Moving suggestions to their categories)
Line 1,207: Line 1,207:
='''Suggested additions to this page'''= <!--T:278-->
='''Suggested additions to this page'''= <!--T:278-->


===2013: [https://journals.asm.org/doi/10.1128/cvi.00636-12?permanently=true Targeting the “Cytokine Storm” for Therapeutic Benefit]===


===2006: [https://www.academia.edu/17983526/The_reinforcing_effects_of_nicotine_and_stimulant_medication_in_the_everyday_lives_of_adult_smokers_with_ADHD_A_preliminary_examination  The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination]===
===2006: [https://www.academia.edu/17983526/The_reinforcing_effects_of_nicotine_and_stimulant_medication_in_the_everyday_lives_of_adult_smokers_with_ADHD_A_preliminary_examination  The reinforcing effects of nicotine and stimulant medication in the everyday lives of adult smokers with ADHD: A preliminary examination]===
Line 1,267: Line 1,266:


===[https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== <!--T:298-->
===[https://pubmed.ncbi.nlm.nih.gov/32595653/ Cytokine Release Syndrome (CRS) and Nicotine in COVID-19 Patients: Trying to Calm the Storm]=== <!--T:298-->
===[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592351/ Targeting the “Cytokine Storm” for Therapeutic Benefit]=== <!--T:299-->


===2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 [https://n.neurology.org/content/78/2/91.short Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial]=== <!--T:300-->
===2010 [https://pubmed.ncbi.nlm.nih.gov/20414766/ Meta-analysis of the acute effects of nicotine and smoking on human performance] and 2012 [https://n.neurology.org/content/78/2/91.short Nicotine treatment of mild cognitive impairment A 6-month double-blind pilot clinical trial]=== <!--T:300-->
Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Navigation menu